6-K 1 f6k_050925.htm FORM 6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2025

 

Commission File Number: 001-41421

 

Alvotech
(Translation of registrant's name into English)

 

9, Rue de Bitbourg,
L-1273 Luxembourg,
Grand Duchy of Luxembourg

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

 

 

 

 

 

 

Incorporation by Reference

 

This Report on Form 6-K (this “Report”) of Alvotech (the “Company”), shall be deemed to be incorporated by reference into the Company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111 and 333-281684) and the Company’s registration statement on Form S-8 (File No. 333-266881) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Exhibit 99.1 to this Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

Management Transaction Notice

 

On May 9, 2025, Alvotech announced that Robert Wessman, Chairman and CEO had filed a form regarding transactions of managers and closely associated persons, with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF), to announce the acquisition of 300,000 shares in Alvotech at a price of ISK 1,255 per share (USD 9.67 at the current exchange rate published by the Central Bank of Iceland). A copy of the form is furnished herewith as exhibit 99.1.

 

 

 

 

EXHIBIT INDEX

 

 

 

Exhibit Number   Description
     
99.1   Management Transaction Notice

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

        Alvotech    
    (Registrant)
     
     
Date: May 9, 2025       /s/ Tanya Zharov    
    Tanya Zharov
    General Counsel